Lipopolysaccharide triggered TNF-α-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model

Journal of Hepatology

Volumn 51, Issue 1, 2009, Pages 168-175

  Kudo, Hiroshi ^a   Takahara, Terumi ^a   Yata, Yutaka ^a,b   Kawai, Kengo ^a   Zhang, Wei ^a   Sugiyama, Toshiro ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b SAISEIKAI MAEBASHI HOSPITAL   (Japan)

Author keywords

Apoptosis; Fibrosis; Lipopolysaccharide; Non alcoholic steatohepatitis; Oxidative stress; Tumour necrosis factor

Indexed keywords

CD14 ANTIGEN; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDE; MESSENGER RNA; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; LIVER CELL; MACROPHAGE; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD14; APOPTOSIS; CASPASE 3; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FATTY LIVER; HEPATOCYTES; HYDROGEN PEROXIDE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MALE; MAP KINASE KINASE KINASE 5; MICE; MICE, INBRED C57BL; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67349139869     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.02.032     Document Type: Article

References (35)

1. Roberts E.A. Nonalcoholic steatohepatitis in children. Curr Gastroenterol Rep 5 (2003) 253-259
2. Powell E.E., Cooksley W.G.E., Hanson R., Searle J., Halliday J.W., and Powell L.W. The natural history of nonalcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years. Hepatology 11 (1990) 74-80
3. Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., and McCullough A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116 (1999) 1413-1419
4. Menon K.V., Gores G.J., and Shah V.H. Pathogenesis, diagnosis, and treatment of alcoholic liver disease. Mayo Clin Proc 76 (2001) 1021-1029
5. Iimuro Y., Gallucci R.M., Luster M.I., Kono H., and Thurman R.G. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26 (1997) 1530-1537
6. Adachi Y., Moore L.E., Bradford B.U., Gao W., and Thurman R.G. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108 (1995) 218-224
7. Nanji A.A., Khettry U., and Sadrzadeh S.M. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med 205 (1994) 243-247
8. Wigg A.J., Roberts-Thomson I.C., Dymock R.B., McCarthy P.J., Grose R.H., and Cummins A.G. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48 (2001) 206-211
9. Li Z., Yang S., Lin H., Huang J., Watkins P.A., Moser A.B., et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37 (2003) 343-350
10. Loguercio C., De Simone T., Federico A., Terracciano F., Tuccillo C., Di Chicco M., et al. Gut-liver axis: a new point of attack to treat chronic liver damage?. Am J Gastroenterol 97 (2002) 2144-2146
11. Takahara T., Xue F., Mazzone M., Yata Y., Nonome K., Kanayama M., et al. Metron factor-1 prevents liver injury without promoting tumor growth and metastasis. Hepatology 47 (2008) 2010-2025
12. Han J., Huez G., and Beutler B. Interactive effects of the tumor necrosis factor promoter and 3′-untranslated regions. J Immunol 146 (1991) 1843-1848
13. Su G.L. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 283 (2002) 256-265
14. Brun P., Castagliuolo I., Floreani A.R., Buda A., Blasone L., Palù G., et al. Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region. Gut 55 (2006) 1212
15. Järveläinen H.A., Orpana A., Perola M., Savolainen V.T., Karhunen P.J., and Lindros K.O. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 33 (2001) 1148-1153
16. Tomita M., Yamamoto K., Kobashi H., Ohmoto M., and Tsuji T. Immunohistochemical phenotyping of liver macrophages in normal and diseased human liver. Hepatology 20 (1994) 317-325
17. Haziot A., Ferrero E., Lin X.Y., Stewart C.L., and Goyert S.M. CD14-deficient mice are exquisitely insensitive to the effects of LPS. Prog Clin Biol Res 392 (1995) 349-351
18. Ferrero E., Jiao D., Tsuberi B.Z., Tesio L., Rong G.W., Haziot A., et al. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 90 (1993) 2380-2384
19. Rivera C.A., Adegboyega P., van Rooijen N., Tagalicud A., Allman M., and Wallace M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol 47 (2007) 571-579
20. Szabo G., Velayudham A., Romics Jr. L., and Mandrekar P. Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. Alcohol Clin Exp Res 29 (2005) 140-145
21. Feldstein A.E., Canbay A., Angulo P., Taniai M., Burgart L.J., Lindor K.D., et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125 (2003) 437-443
22. Wieckowska A., Zein N.N., Yerian L.M., Lopez A.R., McCullough A.J., and Feldstein A.E. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44 (2006) 27-33
23. Pham C.G., Papa S., Bubici C., Zazzeroni F., and Franzoso G. Oxygen JNKies: phosphatases overdose on ROS. Dev Cell 8 (2005) 452-454
24. Wajant H., Pfizenmaier K., and Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 10 (2003) 45-65
25. Bradham C.A., Plümpe J., Manns M.P., Brenner D.A., and Trautwein C. Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol 275 (1998) 387-392
26. Fernández-Checa J.C., Kaplowitz N., Garci{dotless}́a-Ruiz C., and Colell A. Mitochondrial glutathione: importance and transport. Semin Liver Dis 18 (1998) 389-401
27. Han D., Hanawa N., Saberi B., and Kaplowitz N. Hydrogen peroxide and redox modulation sensitize primary mouse hepatocytes to TNF-induced apoptosis. Free Radic Biol Med 41 (2006) 627-639
28. Ludwig J., McGill D.B., and Lindor K.D. Review: nonalcoholic steatohepatitis. J Gastroenterol Hepatol 12 (1997) 398-403
29. Kahraman A., Barreyro F.J., Bronk S.F., Werneburg N.W., Mott J.L., Akazawa Y., et al. TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse. Hepatology 47 (2008) 1317-1330
30. Canbay A., Feldstein A.E., Higuchi H., Werneburg N., Grambihler A., Bronk S.F., et al. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 38 (2003) 1188-1198
31. Canbay A., Friedman S., and Gores G.J. Apoptosis: the nexus of liver injury and fibrosis. Hepatology 39 (2004) 273-278
32. Tobiume K., Matsuzawa A., Takahashi T., Nishitoh H., Morita K., Takeda K., et al. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2 (2001) 222-228
33. Hatai T., Matsuzawa A., Inoshita S., Mochida Y., Kuroda T., Sakamaki K., et al. Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activation. J Biol Chem 275 (2000) 26576-26581
34. Sakon S., Xue X., Takekawa M., Sasazuki T., Okazaki T., Kojima Y., et al. NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 22 (2003) 3898-3909
35. Kamata H., Honda S., Maeda S., Chang L., Hirata H., and Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005) 649-661